0001611793-20-000002.txt : 20201230 0001611793-20-000002.hdr.sgml : 20201230 20201230172902 ACCESSION NUMBER: 0001611793-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201230 DATE AS OF CHANGE: 20201230 EFFECTIVENESS DATE: 20201230 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ONL Therapeutics, Inc. CENTRAL INDEX KEY: 0001611793 IRS NUMBER: 464627845 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-384866 FILM NUMBER: 201426845 BUSINESS ADDRESS: STREET 1: 1600 HURON PARKWAY STREET 2: BUILDING 520, SECOND FLOOR CITY: ANN ARBOR STATE: MI ZIP: 48109 BUSINESS PHONE: 734-926-5530 MAIL ADDRESS: STREET 1: 1600 HURON PARKWAY STREET 2: BUILDING 520, SECOND FLOOR CITY: ANN ARBOR STATE: MI ZIP: 48109 D 1 primary_doc.xml X0708 D LIVE 0001611793 ONL Therapeutics, Inc. 1600 HURON PARKWAY BUILDING 520, SECOND FLOOR ANN ARBOR MI MICHIGAN 48109 734-926-5530 DELAWARE None None Corporation true David Zacks 1600 HURON PARKWAY BUILDING 520, SECOND FLOOR ANN ARBOR MI MICHIGAN 48109 Executive Officer Director Mark Hooper 1600 HURON PARKWAY BUILDING 520, SECOND FLOOR ANN ARBOR MI MICHIGAN 48109 Director David Esposito 1600 HURON PARKWAY BUILDING 520, SECOND FLOOR ANN ARBOR MI MICHIGAN 48109 Executive Officer Director Stella Robertson 1600 HURON PARKWAY BUILDING 520, SECOND FLOOR ANN ARBOR MI MICHIGAN 48109 Director Bill Burns 1600 HURON PARKWAY BUILDING 520, SECOND FLOOR ANN ARBOR MI MICHIGAN 48109 Director Biotechnology Decline to Disclose 06b false 2020-12-18 false true false 0 47359054 26802122 20556932 false 44 0 0 0 false ONL Therapeutics, Inc. David Esposito David Esposito CEO & President 2020-12-30